Pretreatment nutritional status and response to checkpoint inhibitors in lung cancer

Lignende værker

• Simple parameters to solve a complex issue: predicting response to checkpoint inhibitor therapy in lung cancer
  af: Newman, James, et al.
  Udgivet: (2020)
• Burden of Proof: Evaluating the Efficacy of Tumor Mutational Burden (TMB) in Predicting Response to Immune Checkpoint Inhibitors
  af: Newman, James, et al.
  Udgivet: (2020)
• A Comprehensive Review of Contemporary Literature for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer and Their Toxicity
  af: Lee, Chung-Shien, et al.
  Udgivet: (2020)
• Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer
  af: Wang, Kevin Y, et al.
  Udgivet: (2021)
• New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab
  af: Seetharamu, Nagashree, et al.
  Udgivet: (2017)